We are recruiting PPSP patients who:
Are Female
Are 18 years and older.
Believe they have suspected or is symptomatic for Urinary Tract Infection (UTI).
Are willing to take investigative medications to treat their UTI (Study sponsored by GlaxoSmithKline Research)
Are willing to sign consents to participate in the study.
Are willing to participate in the study for a duration of approximately 28 days with 4 scheduled study visits.
Are of childbearing potential (WOCBP) and is not pregnant
Are willing to abstain from sexual activity for up to 2 weeks
Are willing to be paid at each scheduled study visit (summing up to $398 at end of study participation).
This Phase III study’s aim is to evaluate the therapeutic response and clinical efficacy of oral gepotidacin compared to oral nitrofurantoin for acute cystitis(UTI) in adolescent and adult female participants.